Insights from 2023 IMS Annual Meeting
Playback speed
10 seconds
Linvoseltamab for R/R MM: LINKER-MM1 Trial Results From IMS 2023
By
Oncology Data Advisor
FEATURING
Madhav Dhodapkar
By
Oncology Data Advisor
FEATURING
Madhav Dhodapkar
0 views
October 23, 2023
Comments 0
Login to view comments.
Click here to Login
Videos